Wyeth Cited For Not Identifying Cause of Discoloration of Epinephrine Units
Wyeth-Ayerst has not identified the chromophore responsible for the discoloration of samples from epinephrine injection lots approximately 25 months or older, a FDA warning letter states.
You may also be interested in...
Wyeth-Ayerst has been working on process improvements at its Marietta, Penn. plant for six months, the company said following a June 15 seizure action filed by FDA against products produced at the facility.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011